Moroccan hiv test shortages highlight flaws in public procurement policies

Public health centers across Morocco have faced critical shortages of rapid HIV test kits for over a year, forcing patients to leave without screening while local manufacturers hold ready-to-ship supplies. This paradox isn’t merely a logistical failure—it exposes systemic flaws in the country’s public procurement system, where national preference laws remain largely ignored despite clear legal mandates.

legal framework vs. implementation gap

Moroccan law explicitly requires public tenders to prioritize domestic production. Decree No. 2.22.431 mandates that technical specifications must focus on performance and function rather than brand, origin, or patents. Yet, as noted by Abdelhay Rhorba, public law expert at University Hassan II of Casablanca, these rules are frequently circumvented.

«Excessively detailed technical conditions or certifications held exclusively by foreign competitors create unjustified exclusion effects», he explains. «Such practices may constitute an abuse of power and can be legally challenged». Administrative courts assess these cases by evaluating whether specifications unfairly exclude local producers, even when formally compliant.

contradictions in health sector procurement

Healthcare professionals report that cahiers des prescriptions spéciales (CPS)—technical bid documents—are routinely drafted based on imported products already in use, perpetuating outdated procurement cycles rather than adapting to new domestic capabilities. A Moroccan medical device manufacturer, speaking anonymously, shared a Kafkaesque reality: «Our certified products are sold across Africa, yet we hold less than 2% of the domestic public market in our segment because tenders ignore local alternatives».

When local producers flag biased tender conditions favoring foreign suppliers, responses from contracting authorities are often met with silence or inaction. The contradiction extends beyond the Ministry of Health—even as the Ministry of Finance raises import tariffs on medical devices to boost local industry, the health sector continues purchasing costly imported alternatives while overlooking competitively priced domestic options.

ministry’s response falls short

The Ministry of Health asserts it operates «strictly within regulatory frameworks», claiming tenders are open to all operators meeting requirements, with «special attention given to Moroccan-based companies». However, this distinction refers to business registration, not product origin—allowing foreign-owned importers to compete on equal footing with domestic manufacturers.

Regarding HIV test shortages lasting over a year in some facilities, the ministry attributes delays to «procurement procedural timelines and global supply chain disruptions». While admitting «occasional stock tensions», it denies using direct procurement methods, vowing to secure supply through tenders and explore «complementary alternatives». Yet industry observers question why local producers with available, certified stock weren’t engaged during these prolonged shortages.

Under Moroccan law, direct procurement is permissible only under strict conditions: extreme urgency, justified technical exclusivity, or failed tenders—requirements that demand written justification and proof of no alternatives. Failure to comply risks legal invalidation, Rhorba warns: «Unmotivated direct procurement constitutes a violation of public procurement law».

sovereign health ambitions vs. reality

Jaafar Heikel, a leading infectious disease specialist, highlights the broader implications: «While conventional lab tests exist, rapid HIV tests enable outreach to populations that avoid traditional healthcare settings». Their absence undermines prevention efforts, particularly for NGOs conducting door-to-door screening.

Local production validation would offer financial benefits and advance Morocco’s goal of health sovereignty. Yet persistent procurement biases discourage investment in domestic industry at a time when the country urgently needs self-sufficiency.

2030 targets at risk

Morocco has committed to the UNAIDS 95-95-95 targets: diagnosing 95% of people living with HIV, treating 95%, and achieving viral suppression in 95%. These goals hinge on accessible, rapid testing. «Without tests, fewer people get tested, and the virus spreads», warns a local manufacturer. Heikel agrees: «Validated local production would accelerate progress toward these targets».

The Ministry of Health claims full mobilization to ensure testing continuity, but industry players await concrete changes in tender specifications. Increasingly, stakeholders question whether some procurement commission members prioritize foreign suppliers’ interests over national directives—and at what cost to Morocco’s health sovereignty.